Cargando…
Potential therapeutic targets from Mycobacterium abscessus (Mab): recently reported efforts towards the discovery of novel antibacterial agents to treat Mab infections
Mycobacterium abscessus (Mab) are rapidly growing mycobacteria that cause severe and persistent infections in both skin and lung tissues. Treatment regimens involve the extended usage of complex combinations of drugs, often leading to severe adverse side effects, particularly in immunocompromised pa...
Autores principales: | Addison, William, Frederickson, Martyn, Coyne, Anthony G., Abell, Chris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
RSC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020770/ https://www.ncbi.nlm.nih.gov/pubmed/35647542 http://dx.doi.org/10.1039/d1md00359c |
Ejemplares similares
-
The usefulness of change in CT score for evaluating the activity of Mycobacterium abscessus (Mab) pulmonary disease (Mab-PD)
por: Shinfuku, Kyota, et al.
Publicado: (2023) -
Characterization of the cluster MabR prophages of Mycobacterium abscessus and Mycobacterium chelonae
por: Cote, Jacob, et al.
Publicado: (2022) -
MabsBase: A Mycobacterium abscessus Genome and Annotation Database
por: Heydari, Hamed, et al.
Publicado: (2013) -
Correction: MabsBase: A Mycobacterium abscessus Genome and Annotation Database
por: Heydari, Hamed, et al.
Publicado: (2013) -
MAB_2355c Confers Macrolide Resistance in Mycobacterium abscessus by Ribosome Protection
por: Guo, Qi, et al.
Publicado: (2021)